Galectin-3 in the pathogenesis of heart failure: a causative mediator or simply a biomarker?

Am J Physiol Heart Circ Physiol. 2018 Jun 1;314(6):H1256-H1258. doi: 10.1152/ajpheart.00150.2018. Epub 2018 Mar 2.

Authors

Jonathan A Kirk¹, Nikolaos G Frangogiannis²

Affiliations

¹ Department of Cell and Molecular Physiology, Loyola University Chicago Stritch School of Medicine , Maywood, Illinois.
² Division of Cardiology, Department of Medicine, Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine , New York, New York.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
Cardiomyopathies
Galectin 3*
Heart Failure*
Humans

Substances

Biomarkers
Galectin 3

Grants and funding